奧麥羅製藥 OMER 深 滬
等待開盤 12-02 09:30:00 美东时间
9.68
-0.010
-0.10%
華盛通- 最 高10.41
- 今 開9.83
- 成交量 257.52万股
- 最 低 9.5601
- 昨 收 9.69
- 總市值 6.59亿
- 52周最高 13.60
- 市盈率 靜 --
- 換手率 3.78%
- 52周最低 2.95
- 委 比 -66.78%
- 總股本 6805.58万
- 歷史最高 30.23
- 量 比 1.93
- 振 幅 8.77%
- 歷史最低 0.92
- 每 手 1
- 風險率 2.53%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 超配！BETA、BillionToOne获多家机构首予评级；摩根大通上调阿斯麦目标价升至1275美元
今日重点评级关注：RBC Capital：上调Neumora Therapeutics评级至"跑赢大市"，目标价从4美元升至7美元；HC Wainwright & Co.：维持ProMIS Neurosciences"买入"评级，目标价从4美元升至18美元
今天 09:50
D. Boral Capital Maintains Buy on Omeros, Maintains $36 Price Target
D. Boral Capital analyst Jason Kolbert maintains Omeros (NASDAQ:OMER) with a Buy and maintains $36 price target.
今天 02:22
Figure Technology Stock Is Soaring: What's Going On?
Figure Technology Solutions Inc (NYSE:FIGR) shares are rising today after the company released its third-quarter fiscal report with higher than expected financial results.
11-15 03:47
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday
U.S. stocks were lower, with the Dow Jones index falling more than 500 points o...
11-14 22:54
Why RLX Technology Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Shares of RLX Technology Inc – ADR (NYSE:RLX) rose sharply in pre-market tradin...
11-14 18:52
Omeros Q3 Adj. EPS $(0.34) Beats $(0.45) Estimate
Omeros (NASDAQ:OMER) reported quarterly losses of $(0.34) per share which beat the analyst consensus estimate of $(0.45) by 23.6 percent. This is a 46.88 percent increase over losses of $(0.64) per share from the same
11-14 05:28
Earnings Scheduled For November 13, 2025
Companies Reporting Before The Bell • Edgewell Personal Care (NYSE:EPC) is proj...
11-13 19:11
Examining the Future: Omeros's Earnings Outlook
Omeros (NASDAQ:OMER) is preparing to release its quarterly earnings on Thursday...
11-12 23:02
Novo Nordisk Q3 Earnings Preview: New CEO, Board Overhaul — Can the U.S. Weight-Loss Market Turn Around?
TradingKey - Novo Nordisk (NVO), one of Europe’s pharmaceutical giants and a leader in the weight-loss drug race, will report its Q3 2025 earnings before market open on November 5. Wall Street expects a modest rebound from Q2’s worst growth in four years, but significant pressure on profits remains.
11-04 10:56
美股牛股 | 奥麦罗制药隔夜暴涨154.2%！与诺和诺德达成重要战略合作；AI服务供应商VERI涨53.7%
奥麦罗制药隔夜暴涨154.2%！与诺和诺德达成重要战略合作；AI服务供应商VERI涨53.7%，预订量激增及Q3业绩好于预期>>
10-16 15:09
